Biochemical epidemiology of gallbladder cancer

作者: B L Strom , R D Soloway , J Rios-Dalenz , H A Rodriguez-Martinez , S L West

DOI: 10.1002/HEP.510230616

关键词: Lithocholic acidPathogenesisUrsodeoxycholateBile acidInternal medicineTaurineCarcinoembryonic antigenEndocrinologyCholesterolMedicineGallbladder cancer

摘要: To evaluate the a priori hypotheses that an increased level of glyco and tauro lithocholic acid, perhaps because decreased capacity for hepatic sulfation, contributed to biochemical epidemiology gallbladder cancer, case-control study was undertaken at four hospitals in La Paz, Bolivia, one hospital Mexico City, Mexico. Eighty-four cases with newly diagnosed histologically confirmed cancer were compared 264 controls cholelithiasis or choledocholithiasis absence 126 normal biliary tracts. All subjects undergoing abdominal surgery. Interview data collected all subjects, as well blood, bile, gallstone specimens when feasible. Sera analyzed carcinoembryonic antigen, cholesterol concentration, total bile acids. Bile antigen; concentration salts; cholesterol; phospholipids; glycine taurine conjugates cholic, ursodeoxycholic, chenodeoxycholic, deoxycholic, lithocholates; sulfoglycolithocholate; sulfotaurolithocholate. Gallstone percentage content, calcium bilirubinate carbonate content. Serum acids versus two control groups (median 11.7 nmol/mL vs. 9.3 stone 8.2 nmol/L nonstone controls, P < = .02 each pairwise comparison). Biliary markedly 3.98 micromol/mL 33.09 micromol/mL, 154.0 micromol/L, respectively, .0001 comparison), even after excluding those serum bilirubin higher than 2.0 mg/dL. lower 1.70 4.90 16.81 micromol/ mL, .02), phospholipids 2.97 6.26 52.69 .1 .0004, respectively). Contrary our hypothesis, there no difference between either group their concentrations lithocholate, proportion which sulfated, nonsulfated lithocholate. However, had ursodeoxycholate (UDC) (P .004 both groups), especially glycoursodeoxycholate .001 groups). A previously published suggestion size differed not confirmed. In conclusion, from stones tracts biochemistries. These findings may be reflection disease process, provide useful clues its pathogenesis.

参考文章(32)
Bruce W. Trotman, Thomas A. Morris, Harry M. Sanchez, Roger D. Soloway, J. Donald Ostrow, Pigment Versus Cholesterol Cholelithiasis: Identification and Quantification by Infrared Spectroscopy Gastroenterology. ,vol. 72, pp. 495- 498 ,(1977) , 10.1016/S0016-5085(77)80263-1
Paul Talalay, Enzymic Analysis of Steroid Hormones Methods of Biochemical Analysis. ,vol. 8, pp. 119- 143 ,(1960) , 10.1002/9780470110249.CH3
Liese L. Abell, Betty B. Levy, Bernard B. Brodie, Forrest E. Kendall, A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. Journal of Biological Chemistry. ,vol. 195, pp. 357- 366 ,(1952) , 10.1016/S0021-9258(19)50907-3
Peter R. Galle, Lorenz Theilmann, Richard Raedsch, Gerd Otto, Adolf Stiehl, Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes Hepatology. ,vol. 12, pp. 486- 491 ,(1990) , 10.1002/HEP.1840120307
Andrew K. Diehl, Gallstone Size and the Risk of Gallbladder Cancer JAMA: The Journal of the American Medical Association. ,vol. 250, pp. 2323- 2326 ,(1983) , 10.1001/JAMA.1983.03340170049027
S. Ota, H. Tsukahara, A. Terano, Y. Hata, H. Hiraishi, H. Mutoh, T. Sugimoto, Protective effect of tauroursodeoxycholate against chenodeoxycholate-induced damage to cultured rabbit gastric cells Digestive Diseases and Sciences. ,vol. 36, pp. 409- 416 ,(1991) , 10.1007/BF01298867
JAIME RIOS-DALENZ, ARIMICHI TAKABAYASHI, DONALD E HENSON, BRIAN L STROM, ROGER D SOLOWAY, The Epidemiology of Cancer of the Extra-Hepatic Biliary Tract in Bolivia International Journal of Epidemiology. ,vol. 12, pp. 156- 160 ,(1983) , 10.1093/IJE/12.2.156
Masahide Yoshikawa, Tadasu Tsujii, Keisuke Matsumura, Junnichi Yamao, Yoshinobu Matsumura, Ryouichi Kubo, Hiroshi Fukui, Shigeaki Ishizaka, Immunomodulatory effects of ursodeoxycholic acid on immune responses Hepatology. ,vol. 16, pp. 358- 364 ,(1992) , 10.1002/HEP.1840160213